Literature DB >> 25814489

Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.

Vilhjálmur Steingrímsson1, Sigrún Helga Lund1, Ingemar Turesson2, Lynn R Goldin3, Magnus Björkholm4, Ola Landgren5, Sigurdur Y Kristinsson6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25814489      PMCID： PMC4375112          DOI： 10.1182/blood-2015-01-622068

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.

Authors:  Sigurdur Y Kristinsson; Sandra Eloranta; Paul W Dickman; Therese M-L Andersson; Ingemar Turesson; Ola Landgren; Magnus Björkholm
Journal:  Am J Hematol       Date:  2012-11-19       Impact factor: 10.047

2.  Clinical features and outcome of familial chronic lymphocytic leukemia.

Authors:  Francesca R Mauro; Elena Giammartini; Massimo Gentile; Isabella Sperduti; Veronica Valle; Antonio Pizzuti; Anna Guarini; Diana Giannarelli; Robin Foà
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

3.  Characterization of familial Waldenstrom's macroglobulinemia.

Authors:  S P Treon; Z R Hunter; A Aggarwal; E P Ewen; S Masota; C Lee; D Ditzel Santos; E Hatjiharissi; L Xu; X Leleu; O Tournilhac; C J Patterson; R Manning; A R Branagan; C C Morton
Journal:  Ann Oncol       Date:  2005-12-15       Impact factor: 32.976

Review 4.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

5.  Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Mary L McMaster; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2008-08-13       Impact factor: 22.113

6.  Survival in non-Hodgkin's lymphoma by histology and family history.

Authors:  Jianguang Ji; Asta Försti; Jan Sundquist; Per Lenner; Kari Hemminki
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-17       Impact factor: 4.553

7.  Survival patterns among lymphoma patients with a family history of lymphoma.

Authors:  Lesley A Anderson; Ruth M Pfeiffer; Joshua S Rapkin; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

8.  Familial disease predisposition impacts treatment outcome in patients with Waldenström macroglobulinemia.

Authors:  Steven P Treon; Christina Tripsas; Christina Hanzis; Leukothea Ioakimidis; Christopher J Patterson; Robert J Manning; Patricia Sheehy; Barry Turnbull; Zachary R Hunter
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-17
  8 in total
  7 in total

Review 1.  Waldenström Macroglobulinemia: Review of Pathogenesis and Management.

Authors:  Seongseok Yun; Ariel C Johnson; Onyemaechi N Okolo; Stacy J Arnold; Ali McBride; Ling Zhang; Rachid C Baz; Faiz Anwer
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-03-07

Review 2.  Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.

Authors:  Prashant Kapoor; Jonas Paludo; Stephen M Ansell
Journal:  Curr Treat Options Oncol       Date:  2016-03

3.  Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.

Authors:  Jorge J Castillo; Ramon Garcia-Sanz; Evdoxia Hatjiharissi; Robert A Kyle; Xavier Leleu; Mary McMaster; Giampaolo Merlini; Monique C Minnema; Enrica Morra; Roger G Owen; Stephanie Poulain; Marvin J Stone; Constantine Tam; Marzia Varettoni; Meletios A Dimopoulos; Steven P Treon; Efstathios Kastritis
Journal:  Br J Haematol       Date:  2016-07-05       Impact factor: 6.998

4.  Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization.

Authors:  Maroulio Pertesi; Perrine Galia; Nicolas Nazaret; Maxime Vallée; Laurent Garderet; Xavier Leleu; Hervé Avet-Loiseau; Matthieu Foll; Graham Byrnes; Joel Lachuer; James D McKay; Charles Dumontet
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 5.  Waldenstrom's Macroglobulinemia: An Update.

Authors:  Maddalena Mazzucchelli; Anna Maria Frustaci; Marina Deodato; Roberto Cairoli; Alessandra Tedeschi
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

6.  A Single-Center Retrospective Study to Investigate the Follow-Up of Patients with Monoclonal Proteinemia by Community Physicians in the UK.

Authors:  Indra Ramasamy
Journal:  J Blood Med       Date:  2020-06-11

Review 7.  Waldenström macroglobulinemia treatment algorithm 2018.

Authors:  Morie A Gertz
Journal:  Blood Cancer J       Date:  2018-05-01       Impact factor: 11.037
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.